VVA
KRON

Vida Ventures Advisors’s Kronos Bio KRON Stock Holding History

Vida Ventures Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,765,314
Closed -$2.28M – 3
2025
Q1 		$2.28M Hold
2,765,314
– – 16.73% 3
2024
Q4 		$2.63M Hold
2,765,314
– – 1.8% 6
2024
Q3 		$2.77M Hold
2,765,314
– – 2% 6
2024
Q2 		$3.43M Hold
2,765,314
– – 3.75% 5
2024
Q1 		$3.59M Hold
2,765,314
– – 2% 5
2023
Q4 		$3.46M Hold
2,765,314
– – 4.12% 6
2023
Q3 		$3.59M Hold
2,765,314
– – 5.56% 4
2023
Q2 		$4.76M Hold
2,765,314
– – 6.21% 6
2023
Q1 		$4.04M Hold
2,765,314
– – 5.52% 6
2022
Q4 		$4.48M Hold
2,765,314
– – 6.02% 5
2022
Q3 		$9.26M Hold
2,765,314
– – 8.31% 5
2022
Q2 		$10.1M Hold
2,765,314
– – 8.51% 5
2022
Q1 		$20M Hold
2,765,314
– – 11.63% 5
2021
Q4 		$37.6M Hold
2,765,314
– – 14.06% 4
2021
Q3 		$58M Hold
2,765,314
– – 16.6% 3
2021
Q2 		$66.2M Hold
2,765,314
– – 16.61% 2
2021
Q1 		$80.9M Hold
2,765,314
– – 20.45% 3
2020
Q4 		$82.6M Buy
+2,765,314
New +$86.8M 16.95% 3

Vida Ventures Advisors's KRON Position: Q2 2025 in Review

Vida Ventures Advisors sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 2,765,314 shares — an estimated $2.28M sold.

Vida Ventures Advisors first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $82.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • Vida Ventures Advisors reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • Vida Ventures Advisors sold 2,765,314 Kronos Bio shares in Q2 2025, an estimated $2.28M.
  • Vida Ventures Advisors first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
  • Vida Ventures Advisors's Kronos Bio position peaked at $82.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Vida Ventures Advisors's 13F filing for Q2 2025, filed 10 Jul 2025.